Medtech

Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.

Professor Hans von Holst is in his element where different disciplines intersect – where medicine meets technology. This is where his ideas have helped create, amongst other breakthroughs, MIPS, a technology that improves the protective properties of everyday helmets. Since 2011, the company has delivered around nine million helmets worldwide.

Staffan Holmin has developed a microcatheter that delivers drugs and cells directly to the body’s organs via blood vessels. The next step is to take samples from organs that are hard or too risky to reach with other methods. The key to success is an interdisciplinary team with a variety of core skill sets.